You just read:

Bayer Collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP) to Investigate Stivarga® (Regorafenib) Tablets as Additional Adjuvant Therapy in Colon Cancer

News provided by

Bayer

Jun 01, 2016, 02:30 ET